Suppr超能文献

肠道中乙酰胆碱酯酶的抑制会抑制大鼠的程序控制行为。

Inhibition of acetylcholinesterase in the gut inhibits schedule-controlled behavior in the rat.

作者信息

Brezenoff H E, McGee J, Hymowitz N

出版信息

Life Sci. 1985 Jul 8;37(1):49-54. doi: 10.1016/0024-3205(85)90624-1.

Abstract

Rats were trained to press a lever under a multiple Fixed-Ratio 25 Fixed-Interval 50-second schedule of food reinforcement. Subcutaneous injection of soman, 80 micrograms/kg, suppressed responding under both schedules and inhibited acetylcholinesterase (AChE) in the brain. AChE activity in the gastrointestinal tract was not significantly inhibited. In contrast, i.p. injection of either soman (10-40 micrograms/kg), neostigmine (75 micrograms/kg) or DFP (350 micrograms/kg) caused marked suppression of behavior and AChE activity of the gut, without affecting brain AChE. These doses caused marked increases in peristaltic activity and likely caused gastrointestinal spasm. Injection of DFP, 500 micrograms/kg, s.c., inhibited AChE in both the brain and gut. The results indicate that inhibition of AChE in the gastrointestinal tract by certain anticholinesterase agents may be involved in the behavioral effects attributed to these drugs.

摘要

大鼠被训练在食物强化的多重固定比率25固定间隔50秒的时间表下按压杠杆。皮下注射80微克/千克梭曼,抑制了两种时间表下的反应,并抑制了大脑中的乙酰胆碱酯酶(AChE)。胃肠道中的AChE活性未受到显著抑制。相比之下,腹腔注射梭曼(10 - 40微克/千克)、新斯的明(75微克/千克)或二异丙基氟磷酸酯(DFP,350微克/千克)会导致行为和肠道AChE活性的显著抑制,而不影响大脑AChE。这些剂量会导致蠕动活动显著增加,并可能引起胃肠道痉挛。皮下注射500微克/千克DFP可抑制大脑和肠道中的AChE。结果表明,某些抗胆碱酯酶药物对胃肠道中AChE的抑制作用可能与这些药物的行为效应有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验